Barnidipine: A new calcium channel blocker for hypertension treatment

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 2, 2005, Pages 207-213

  Liau, Chiau Suong ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Antihypertensive treatment; Barnidipine hydrochloride; Calcium channel blocker; Essential hypertension; Patient adherence; Renal parenchymal hypertension; Renovascular hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CIMETIDINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ERYTHROMYCIN; FELODIPINE; HYDROCHLOROTHIAZIDE; MEPIRODIPINE; NICARDIPINE; PLACEBO; SIMVASTATIN; TROGLITAZONE;

ADJUVANT THERAPY; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIURETIC ACTIVITY; DIZZINESS; DOSE CALCULATION; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; NONHUMAN; PATIENT COMPLIANCE; PERIPHERAL EDEMA; RENOVASCULAR HYPERTENSION; SIDE EFFECT; TACHYCARDIA;

CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS; HUMANS; HYPERTENSION; NIFEDIPINE;

EID: 15844374452     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.3.2.207     Document Type: Article

References (28)

1. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National Heart, Lung and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 42, 1206-1252 (2003).
2. European Society of hypertension-European Society of Cardiology. 2003 guidlines for the management of arterial hypertension. J. Hypertens. 21, 1011-1053 (2003).
3. Abe K, on behalf of the J-MUBA Study Group. Overview of the Japanese multicenter study on barnidipine with ambulatory blood pressure monitoring. Blood Press. Monit. 6(Suppl. 2), S3-S7 (2001).
4. Yoshinaga K, Iimura O, Abe K et al Antihypertensive effect and safely of YM730 (mepirodipine hydrochloride) in patients with severe hypertension. Shinryo to Shinyaku 27, 1657-1670 (1990).
5. Yoshinaga K, Iimura O, Abe K et al. Clinical usefulness of barnidipine hyrochloride (YM730), a calcium antogonist, in the treatment of renovascular hypertension (continued report)-aggregate results incorporating additional study. Ther. Res. 15, 3267-3275 (1994).
6. Buranakitjaroen P, Koanantakul B, Phoojaroenchanachai M, Chawantanpipat C. The efficacy and tolerability of barnidipine hydrychloride in Thai patients with hypertension. J. Intl Med. Res. 32, 185-200 (2004)
7. Hypoca®, product information. Yamanouchi Pharmaceutical Co. Ltd, Tokyo, Japan.
8. Teramura T, Watanabe T, Higuchi S, Hashimoto K. Metabolism and pharmacokenetics of barnidipine hydrochloride, a calcium channel blocket, in man following oral administration of its sustained release formulation. Xenobiotica 27, 203-216 (1997).
9. Hashimoto K, Motomura S, Tsujimoto G, Higuchi S, Teramura T. Phase I study of a calcium antagonist, YM730 (mepirodipine hydrochloride). Clin. Rep. 24, 4443-4458 (1990).
10. Park HC, Kwon KH, Noh HJ et al. Open-label, uncontrolled clinical trial of barnidipine parenchymal hypertension. Curr. Ther. Res. Clin. Exp. 61, 927-937 (2000).
11. Beudeker HJ, van der Velden J-W, van der Aar EM. Interaction profile and tolerability of barnidipine. Int. J. Clin. Pract. 114(Suppl.), 36-40 (2000).
12. Korstanje C. Barnidipine, a long-acting slow onset calcium antagonist. Int. J. Clin. Pract. 114(Suppl.), 2-5 (2000).
13. Smilde JG. The long-term efficacy and safety profile of barnidipine. Int. J. Clin. Pract. 114(Suppl.), 20-25 (2000).
14. Naber FB, Hage R, Mortelmans J. Barnidipine monotherapy and combination therapy in older patients with essential hypertension: a long-term study. J. Clin. Pract. 114(Suppl.), 2735 (2000).
15. Hart W, Holwerda NJ. Barnidipine, a novel calcium antogonist for once-daily treatment of hypertension: a multicenter, double-blind, placebo-controlled, dose-ranging study. Cardiovasc. Drug. Ther. 11, 637-643 (1997).
16. Otterstad JE, Ruilope LM. Treatment of hypertension in the very old. Int. J. Clin. Pract. 114(Suppl.) 10-19 (2002).
17. Noda H, Fujita T, Ogara E. The role of renal hemodynamics in the antihypertensive action of mepirodipine, a new calcium antagonist. Jpn. Circ. J. 56, 21-26 (1992).
18. Huh WS, Kim YS, Han JS et al. Antihypertensive efficacy and tolerability of barnidipine hydrochloride in patients with renal parenchymal hypertension. Curr. Ther. Res. Clin. Exp. 61, 395-405 (2005).
19. Yoshinaga K, Iimura O, Abe K et al. Clinical evaluation of YM730 (mepirodipine hydrochloride) in the treatment of essential hypertension: double-blind comparative study with sustained release preparation of nicardipine hydrochloride as control. Igaku No Ayumi 156, 543-560 (1991).
20. Yoshinaga K, Iimura I, Abe K et al. Investigation of clinical usefulness of mepirodipine hydrochloride (YM730), a calcium antagonist, in patients with renovascular hypertension. Jin To Toseki 30, 121-126 (1991).
21. Yoshinaga K, Iimura I, Abe K et al. Investigation of clinical usefulness of mepirodipine hydrochloride (YM730), a calcium antagonist, in patients with renal parenchymal hypertension. Jin To Toseki 26, 1045-1058 (1990).
22. Liau CS, Chien KL, Chao CL, Lee TM. Efficacy and safety of barnidipine compared with felodipine in the treatment of hypertension in Chinese patients. J. Intl. Med. Res. 30, 330-336 (2002).
23. van der Velden JW, Beudeker HJ, Nishi M. Diversity and intensity of advers events in the treatment of hypertension with barnidipine. Blood Press. 7(Suppl. 1), S27-S29 (1998).
24. Malhotra HS, Plosker GL. Barnidipine. Drugs 61, 989-996 (2001).
25. Ruilope LM, Coca A. The role of combination therapy in the treatment of hypertension. Blood Press. 7(Suppl. 1), S22-S26 (1998).
26. Matsuura H, Imai Y, Shimada K, Kuwajima I, Abe K. in behalf of the J-MURA Study Group. Effects of the long-acting calcium channel blocker barnidipine hydrochloride on 24-h ambulatory blood pressure: results of the Japanese Multicenter Study on Barnidipine with Ambulatory Blood Pressure Monitoring. Blood Press. Monit. 6(Suppl. 2), S41-S47 (2001).
27. World Health Organization, International Society of Hypertension Writing Group, World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 21, 1983-1992 (2003).
28. Williams B, Poulter NR, Brown MJ et al. British Hypertension Society guideline. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J. Human Hypertens. 18, 139-185 (2004).